Skip to content
  1. Home/
  2. Latest news/
  3. What you need to know about Johnson & Johnson’s 2025 first-quarter earnings
Johnson & Johnson scientists in lab coats handling pipettes

What you need to know about Johnson & Johnson’s 2025 first-quarter earnings

Here’s an infographic breakdown of the company’s first-quarter earnings results, including highlights from its Innovative Medicine and MedTech businesses.

This morning, Johnson & Johnson shared its 2025 first-quarter earnings report.

Since its founding in 1886, the company has been committed to innovation—today, more than 138,000 employees across the globe work to deliver solutions for patients around the world and to help profoundly impact health for humanity.

Johnson & Johnson’s diversified business model uniquely positions us to navigate challenges while delivering on our financial commitments, advancing an innovative pipeline and creating long-term, sustainable value for shareholders,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Our solid results and strong financial foundation enable us to invest for the future, bolster our portfolio and return capital to our shareholders, as evidenced by today’s announcement of our 63rd consecutive year of dividend increases.”

For more details about the company’s 2025 first-quarter results, and to read a message from Chairman and Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.

Infographic of Q1 2025 Earnings Johnson & Johnson

Johnson & Johnson’s 2025 first-quarter earnings

Read the earnings press release, which includes full financial data for the first quarter of 2025.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

More from Johnson & Johnson

What are clinical trials?

Behind every innovative medicine, treatment and therapy is a clinical trial. To help you understand them better, here’s a closer look at how they work.

Meet two Johnson & Johnson nurse educators dedicated to teaching cancer care providers

Jennifer Huff and Jacqui Mellott are two of Johnson & Johnson’s oncology clinical educators—a team of 50 nurses who visit hospitals and infusion centers to help providers understand and stay up to date with treatments.

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.